Coronary thrombo-embolic events after Covid-19 vaccination
Thrombo-embolic complications after Corona virus disease-19 (COVID-19) vaccination have been previously reported. Study in Indian heart journal reported that the coronary thrombo-embolic complications (CTE) after COVID-19 vaccination in a single centre during the initial 3 months of vaccination drive in India.
Total of the 89 patients with Acute Coronary Syndrome and angiographic evidence of coronary thrombus, 42% had prior vaccination history. Covishield was the most used vaccine- (76%), while only 24% had Covaxin. Baseline characteristics were similar in both vaccinated (VG) and non-vaccinated group (NVG).
Thrombocytopenia was not noted in any of the vaccinated patients, while 3.8% of non-vaccinated group patients had thrombocytopenia. The researchers hence concluded that this is the first report of coronary thrombo-embolic complications after COVID-19 vaccination during the first 3 months of vaccination drive in India. However, further reports are needed to identify the incidence of this rare but serious adverse events following COVID-19 vaccination.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.